Literature DB >> 21326807

Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma presenting as an isolated nasopharyngeal mass: a case report and review of literature.

Ke Li1, Ann M P Tipps, Huan-You Wang.   

Abstract

Anaplastic lymphoma kinase (ALK)-positive diffuse large B-cell lymphoma is a rare and distinct variant of diffuse large B-cell lymphoma with characteristic morphologic, immunophenotypic, and cytogenetic features. We report a case of ALK-positive diffuse large B-cell lymphoma in a 44-year-old male with progressively worsening unilateral nasal congestion and obstruction secondary to a nasopharyngeal mass. Radiologically, the mass was showed to extend to orophanrynx from nasopharynx. Histologically, the tumor cells exhibited plasmablastic morphology with expression of Bob-1, CD4, CD10, CD45, CD56, CD138, EMA, MUM1, Oct-2, and kappa immunoglobulin light chain, but negative for CD20, CD30, CD79a, PAX-5, and lambda. More importantly, the neoplastic cells showed positive immunoreactivity for ALK with exclusive cytoplasmic granular staining pattern. This case represented the second reported ALK-positive diffuse large B-cell lymphoma in the nasopharyngeal region.

Entities:  

Keywords:  Anaplastic lymphoma kinase (ALK); CD10; CD4; diffuse large B-cell lymphoma; nasopharyngeal mass

Mesh:

Substances:

Year:  2010        PMID: 21326807      PMCID: PMC3037206     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  10 in total

1.  ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature.

Authors:  Kaaren K Reichard; Robert W McKenna; Steven H Kroft
Journal:  Mod Pathol       Date:  2007-02-02       Impact factor: 7.842

2.  Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era.

Authors:  Ritsuko Seki; Koichi Ohshima; Tomoaki Fujisaki; Naokuni Uike; Fumio Kawano; Hisashi Gondo; Shigeyoshi Makino; Tetsuya Eto; Yukiyoshi Moriuchi; Fumihiro Taguchi; Tomohiko Kamimura; Hiroyuki Tsuda; Ryosuke Ogawa; Kazuya Shimoda; Kiyoshi Yamashita; Keiko Suzuki; Hitoshi Suzushima; Kunihiro Tsukazaki; Masakazu Higuchi; Atae Utsunomiya; Masahiro Iwahashi; Yutaka Imamura; Kazuo Tamura; Junji Suzumiya; Minoru Yoshida; Yasunobu Abe; Tadashi Matsumoto; Takashi Okamura
Journal:  Cancer Sci       Date:  2009-07-01       Impact factor: 6.716

3.  A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation.

Authors:  G Delsol; L Lamant; B Mariamé; K Pulford; N Dastugue; P Brousset; F Rigal-Huguet; T al Saati; D P Cerretti; S W Morris; D Y Mason
Journal:  Blood       Date:  1997-03-01       Impact factor: 22.113

4.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.

Authors:  A A Alizadeh; M B Eisen; R E Davis; C Ma; I S Lossos; A Rosenwald; J C Boldrick; H Sabet; T Tran; X Yu; J I Powell; L Yang; G E Marti; T Moore; J Hudson; L Lu; D B Lewis; R Tibshirani; G Sherlock; W C Chan; T C Greiner; D D Weisenburger; J O Armitage; R Warnke; R Levy; W Wilson; M R Grever; J C Byrd; D Botstein; P O Brown; L M Staudt
Journal:  Nature       Date:  2000-02-03       Impact factor: 49.962

5.  Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.

Authors:  Kai Fu; Dennis D Weisenburger; William W L Choi; Kyle D Perry; Lynette M Smith; Xinlan Shi; Christine P Hans; Timothy C Greiner; Philip J Bierman; R Gregory Bociek; James O Armitage; Wing C Chan; Julie M Vose
Journal:  J Clin Oncol       Date:  2008-07-28       Impact factor: 44.544

6.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

7.  Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis.

Authors:  Camille Laurent; Catherine Do; Randy D Gascoyne; Laurence Lamant; Loïc Ysebaert; Guy Laurent; Georges Delsol; Pierre Brousset
Journal:  J Clin Oncol       Date:  2009-07-27       Impact factor: 44.544

8.  ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases.

Authors:  Mihaela Onciu; Frederick G Behm; James R Downing; Sheila A Shurtleff; Susana C Raimondi; Zhigui Ma; Stephan W Morris; Wren Kennedy; Sandra C Jones; John T Sandlund
Journal:  Blood       Date:  2003-06-19       Impact factor: 22.113

9.  ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC).

Authors:  Norio Chikatsu; Hiroshi Kojima; Kazumi Suzukawa; Atsushi Shinagawa; Toshiro Nagasawa; Hiroaki Ozawa; Yoriko Yamashita; Naoyoshi Mori
Journal:  Mod Pathol       Date:  2003-08       Impact factor: 7.842

Review 10.  ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature.

Authors:  Brady Beltran; Jorge Castillo; Renzo Salas; Pilar Quiñones; Domingo Morales; Fernando Hurtado; Luis Riva; Eric Winer
Journal:  J Hematol Oncol       Date:  2009-02-27       Impact factor: 17.388

  10 in total
  5 in total

Review 1.  Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma presenting in nasal cavity: a case report and review of literature.

Authors:  Ji Chen; Xiaoli Feng; Mei Dong
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 2.  Promising personalized therapeutic options for diffuse large B-cell Lymphoma Subtypes with oncogene addictions.

Authors:  James J Steinhardt; Ronald B Gartenhaus
Journal:  Clin Cancer Res       Date:  2012-06-27       Impact factor: 12.531

3.  Anaplastic lymphoma kinase-positive large B-cell lymphoma: an underrecognized aggressive lymphoma.

Authors:  Elizabeth A Morgan; Alessandra F Nascimento
Journal:  Adv Hematol       Date:  2012-02-26

Review 4.  Anaplastic lymphoma kinase-positive large B-cell lymphoma: Clinico-pathological study of 17 cases with review of literature.

Authors:  Xiang-Nan Jiang; Bao-Hua Yu; Wei-Ge Wang; Xiao-Yan Zhou; Xiao-Qiu Li
Journal:  PLoS One       Date:  2017-06-30       Impact factor: 3.240

5.  A Rare Case of ALK-Positive Large B-Cell Lymphoma with CD33 Expression.

Authors:  Jessica Corean; K David Li
Journal:  Case Rep Hematol       Date:  2018-06-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.